Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9940909 | 0.78 | CYP3A4 (0.43) | CYP3A4 | |
| SCHEMBL9940520 | 0.78 | CYP3A4 (0.45) | CYP3A4 | |
| SCHEMBL16806083 | 0.78 | CYP3A4 (0.42) | CYP3A4 | |
| SCHEMBL16696095 | 0.77 | TBXAS1 (0.36) | PGR | |
| SCHEMBL16806088 | 0.76 | CYP3A4 (0.59) | CYP3A4 | |
| SCHEMBL9979900 | 0.76 | MAPT (0.36) | CYP3A4 | |
| SCHEMBL16806086 | 0.76 | CYP3A4 (0.41) | CYP3A4 | |
| SCHEMBL16806077 | 0.76 | CYP3A4 (0.41) | CYP3A4 | |
| SCHEMBL16806078 | 0.75 | CYP3A4 (0.40) | CYP3A4 | |
| SCHEMBL17521659 | 0.75 | LMNA (0.37) | PGR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150166533-A1 | NOVEL 1,3-DIHYDRO-2H-BENZIMIDAZOL-2-ONE DERIVATIVES SUBSTITUTED WITH BENZIMIDAZOLES AS RESPIRATORY SYNCYTIAL VIRUS ANTIVIRAL AGENTS | JANSSEN R&D IRELAND (US) | 2015-06-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150166533-A1 | NOVEL 1,3-DIHYDRO-2H-BENZIMIDAZOL-2-ONE DERIVATIVES SUBSTITUTED WITH BENZIMIDAZOLES AS RESPIRATORY SYNCYTIAL VIRUS ANTIVIRAL AGENTS | ZC3HAV1, ZC3HAV1L, SARS1 | CYP3A4 59/4885PGR 2859/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.